6Verbeek DS, Warrenbarg BP, Hennekam FA, et al. Gly118Asp is a SCA14 founder mutation in the Dutch ataxia population[J]. Hum- Genet, 2005, 117:88 - 91.
1Went L. Guildlines for the molecular genetic predictive testing in Huntington's disease. J Med Genet, 1994,31:555-559
2Margolis RL. The spinocerebellar ataxias:orders emerges from chaos. Curr Neurol Neurosci Rep, 2002,2:447-456
3Mahowald WB, Verp MS, Anderson RR. GENETIC COUNSELING: clinical and ethical challenges. Annu Rev Genet, 1998, 32:547-559
4Kirkwood SC, Siemers E, Bood C, et al.Confirmation of subtle motor changes among presymptomatic carriers of the Huntigton disease gene. Arch Neurol, 2000,57(7):1040-1044
5Tan EK, Ashizawa T. Genetic testing in spinocerebellar ataxias: defining a clinical role. Arch Neurol, 2001,58(2):191-195
6Harding AE. Clinical features and classification of inherited ataxias. Adv Neurol, 1993,61:1-14
7Kawaguchi Y, Okamoto T, Taniwaki, et al. CAG expansion in a novel gene for Machado-Joseph disease at chromosome 14q 32.1. Nat Genet, 1994, 8:221-228
8Pulst SM, Nechiporuk T, et al. Moderate expansion of a normary bialletic trinucleotide repeat in spinocerebellar ataxia type 2 gene on human chromosome 12. Nat Genet 1996,14:269-276
9Orr H, Chung MY, Banfi S, et al. Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1. Nat Genet, 1993,4:221-226
10Zhuchenko O, Bailey J, Bonnen P, et al. Autosomal dominant cerebellar ataxia (SCA6) associated with small ployglutamine expansion in the alpha 1A-voltage-dependent calcium channel. Nat Genet, 1997,15:62-69
